Related Experiment Video
Updated: Sep 18, 2025

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Early Administration of Rifampicin Does Not Induce Increased Resistance in Septic Two-Stage Revision Knee and Hip
Leonard Grünwald1,2, Benedikt Paul Blersch1,2, Bernd Fink1,3
1Department of Joint Replacement, General and Rheumatic Orthopaedics, Orthopaedic Clinic Markgröningen gGmbH, Kurt-Lindemann-Weg 10, 71706 Markgröningen, Germany.
Abstract:
Background/Objectives: Periprosthetic joint infection (PJI) is a severe complication that follows arthroplasty and occurs in approximately 2% of all cases. One of several cornerstones of therapy is an optimized antibiotic regimen. Early administration of rifampicin-together with a combination of an antibiotic to which the specific microorganism is susceptible-accompanying a two-stage revision surgery, remained controversial due to the potential risk of emerging resistance. However, the exact time to start rifampicin treatment often remains unclear and might be crucial in the treatment regimen. Methods: In a retrospective study design, a total of 212 patients receiving a two-stage revision surgery after a diagnosis of PJI (60.8% THA, 39.2% TKA) received an individual rifampicin combination therapy after initial debridement and removal of all foreign material, starting rifampicin on the second day postoperatively. Results: At the time of spacer explantation, two patients had developed rifampicin resistance (0.9%). At follow-up (M = 55.4 ± 21.8 months) after reimplantation, three patients had developed rifampicin resistance (1.4%). Concerning the development of reinfection, in general, in the study group and the necessity for further treatment, a total of 25 patients showed signs of reinfection (11.8%). Conclusions: Only 0.9% after the first stage and 1.4% at follow-up after the second stage of all 212 patients with accompanying long-term rifampicin combination therapy developed a rifampicin resistance. Therefore, rifampicin administration could be started on the second postoperative day when sufficient concentrations of the accompanying antibiotics can be expected.
Insights
Starting rifampicin on the second postoperative day for periprosthetic joint infection (PJI) treatment showed low rates of rifampicin resistance (0.9%-1.4%). This timing is safe and effective for two-stage revision surgery in PJI patients.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Pharmacology
Background:
- Periprosthetic joint infection (PJI) is a serious complication following arthroplasty, affecting approximately 2% of patients.
- Optimized antibiotic regimens are crucial for PJI management, with rifampicin often used in combination therapy.
- The optimal timing for initiating rifampicin treatment to prevent resistance remains debated.
Purpose of the Study:
- To evaluate the safety and efficacy of initiating rifampicin combination therapy on the second postoperative day in patients undergoing two-stage revision surgery for PJI.
- To assess the incidence of rifampicin resistance development during and after treatment.
Main Methods:
- Retrospective study of 212 patients with PJI undergoing two-stage revision surgery (THA and TKA).
- Patients received individualized rifampicin combination therapy starting on the second postoperative day after debridement and foreign material removal.
- Rifampicin resistance was monitored at spacer explantation and long-term follow-up.
Main Results:
- A low incidence of rifampicin resistance was observed: 0.9% at spacer explantation and 1.4% at long-term follow-up.
- The overall reinfection rate requiring further treatment was 11.8% in the study group.
- No significant increase in resistance was noted between the first and second stages of surgery.
Conclusions:
- Initiating rifampicin combination therapy on the second postoperative day is associated with a low risk of developing rifampicin resistance in PJI patients.
- This therapeutic approach appears safe and effective for two-stage revision surgery, allowing sufficient concentrations of companion antibiotics.
- Early administration of rifampicin on postoperative day two is a viable strategy in managing periprosthetic joint infections.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Rheumatic Heart Disease III: Medical Management
Endocarditis III: Medical Management

